THE USE OF MULTIDIMENSIONAL LIQUID-PHASE SEPARATIONS AND MASS-SPECTROMETRY FOR THE DETAILED CHARACTERIZATION OF POSTTRANSLATIONAL MODIFICATIONS IN GLYCOPROTEINS

Citation
S. Udiavar et al., THE USE OF MULTIDIMENSIONAL LIQUID-PHASE SEPARATIONS AND MASS-SPECTROMETRY FOR THE DETAILED CHARACTERIZATION OF POSTTRANSLATIONAL MODIFICATIONS IN GLYCOPROTEINS, Analytical chemistry (Washington), 70(17), 1998, pp. 3572-3578
Citations number
25
Categorie Soggetti
Chemistry Analytical
ISSN journal
00032700
Volume
70
Issue
17
Year of publication
1998
Pages
3572 - 3578
Database
ISI
SICI code
0003-2700(1998)70:17<3572:TUOMLS>2.0.ZU;2-U
Abstract
The goal of characterization of the proteome, while challenging in its elf, is further complicated by the microheterogeneity introduced by po sttranslational modifications such as glycosylation. A combination of liquid chromatography (LC), capillary electrophoresis (CE), and mass s pectrometry (MS) offers the advantages of unique selectivity and high efficiency of the separation methods combined with the mass specificit y and sensitivity of MS. In the current work, the combination of liqui d-phase separations and mass spectrometry is demonstrated through the on-line coupling of electrospray ionization mass spectrometry (ESI-MS) and off-line coupling with matrix-assisted laser desorption/ionizatio n time-of-flight mass spectrometry (MALDI TOF-MS). LC/ESI-MS yields re al-time results while maintaining the separation obtained from the LC analysis. CE/MALDI TOF-MS offers high-mass detection and extremely low detection limits. The unique separation selectivity of CE relative to reversed-phase HPLC separations of the members of a glycopeptide fami ly was used to develop an integrated multidimensional analysis achieve d by the off-line coupling of LC, CE, and MALDI TOF-MS, To demonstrate the applicability of these techniques to the characterization of the heterogeneity of posttranslational modifications present in glycoprote ins, we will report on the study of the glycoforms present in a N-link ed site in a single-chain plasminogen activator (DSPA alpha 1).